Suramin (Antrypol)

From - A Hematology Oncology Wiki
Jump to navigation Jump to search

Mechanism of action

Antiparasitic with mechanism of action unclear.

Diseases for which it was used

History of changes in FDA indication

  • This drug is not FDA approved. Of note, it was investigated in prostate cancer but utility was not proven and investigations have been discontinued.